VHD
Navigation Links
VHD at medicine products
Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.Description:VasoSeal VHD was the first device to rapidly stop bleeding after diagnostic and interventional cardiology and radiology procedures. It is a collagen-based vascular sealing device approved for immediate sheath removal post PTA, PTCA, and stent procedures....
Company:Datascope Corp.
Other TagsQueenQueenEngineerEngineerEngineerSilverSilverParticleParticleParticleParticleNanotechNanotechNanotechResistanceResistanceResistanceResistanceNerveNerveNerveNerveExtremeExtremeAbnormalAbnormalAlteredOther Contentsbandbandbandbandbandbandbandbandbarkbarkbarkbarkbasesbasesbasesbasesbasesbasesbasophilsbasophilsbicepsbicepsbellybellybellybellybicuspid
QueenEngineerSilverParticleSpellingFernsNanotechResistancePressuredNerveExtremeComparingAbnormalAltered
(Date:1/7/2009)...years ago, the Chinese National Human Genome Cente...ished ,in the Zhangjiang HiTech Park of Pudong Di...event, ,which marks the beginning of the Genomics...ini-reviews for ,this special issue. We hope that... life science research workers ,to collectively r...
(Date:1/7/2009)...SON, WI, JANUARY 5, 2009 Currently, plant testing...gical risks from chemical pesticides to nontarget ...ure plants. Protection of the plant development an...quired for the protection of animals. Past researc...t plant development/reproduction is not adequately...
(Date:1/7/2009)...ridge, MA January 7, 2009 Phylonix Pharmaceutic... a $1,250,369 Phase II Small Business Innovation R...f General Medical Sciences of the National Institu...ssays for assessing drug effects on Cytochrome (CY...development, is required by the Food and Drug Admi...
(Date:1/6/2009)...IER INTERNATIONAL MEETING HIGHLIGHTS BREAKTHROUGH ...C DIFFERENCES,CAREFREE, AZ,FEBRUARY 3-6, 2009 ,...es in treatment and outcomes among cancer patients...derlying causes and what can be done to solve a se...ion for Cancer Research is hosting a collaboration...
Breaking Biology News(10 mins):Human genomics in China 2Human genomics in China 3Human genomics in China 4Human genomics in China 5Human genomics in China 6Human genomics in China 7Human genomics in China 8Human genomics in China 9Human genomics in China 10Human genomics in China 11NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays 2American Association for Cancer Research hosts Science of Health Care Disparities Meeting 2Alcohol and malt liquor availability and promotion higher in African American inner cities 2734 1Alcohol and malt liquor availability and promotion higher in African American inner cities 2734 2China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent 15858 1China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent 15858 2Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 1Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 2Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 3Uroplasty Plans to Double Sales Force During Fiscal 2009 15857 4Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 1Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 2Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 3Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing 15854 4(Date:1/7/2009)... Applauds Legislation Aimed at Protecting Medicare...h Congress , , ALEXANDRIA, Va., Jan. 7 Physi...uld no longer be limited by arbitrary financial ca...ate and House of Representatives, according to the... , The Medicare Access to Rehabilitation Services ...
(Date:1/7/2009)...llowing is a statement by Lois Aronstein, AARP NY ...e of the State address put forth recommendations o...lth care and financial security of New Yorkers of ...osing to expand the Family Health Plus Program to ...ore than 400,000 additional New Yorkers eligible f...
(Date:1/7/2009)...ied mutations in a gene that predict a high likeli...ic leukemia (ALL). Although the researchers cautio... changes in the gene, called IKZF1 or IKAROS, lead...rovide the basis for future diagnostic tests to as...lecular test to identify this genetic marker in AL...
(Date:1/7/2009)...n. 7 Stryker Corporation,(NYSE: SYK ) announced...nvestor,conference: , , January 14, 200...al J.P. Morgan Healthcare Conference, S...cast of the Company,s presentation will be availab...he For Investors page. The,presentation for the J...
Breaking Medicine News(10 mins):Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene abnormality found to predict childhood leukemia relapse 2Health News:Gene abnormality found to predict childhood leukemia relapse 3Health News:Gene abnormality found to predict childhood leukemia relapse 4Health News:Stryker To Present at Investor Conference 2| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |